Gawande looks to remove waste as he gears up to head healthcare initiative

After his  appointment as CEO of the new Amazon-Berkshire Hathaway-JPMorgan Chase healthcare venture, Atul Gawande, MD, stated the undertaking will look to target wasteful spending, while providing better outcomes and satisfaction and removing “some of the middlemen" from the system.

“My job for them is to figure out ways that we’re going to drive better outcomes, better satisfaction with care and better cost efficiency with new models that can be incubated for all,” Gawande said.

The venture is slated to target three types of waste in the healthcare system including administrative costs, high prices and “improper” healthcare usage, according to reporting from Bloomberg.com.

To read more, click the link below:

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup